PUBLISHER: TechSci Research | PRODUCT CODE: 1255237
PUBLISHER: TechSci Research | PRODUCT CODE: 1255237
Diabetic Foot Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Treatment, By Ulcer Type, By End User, By Region, and Competition
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The global diabetic foot ulcer treatment market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the increasingly leading sedentary lifestyle along with consuming unhealthy food habits. Additionally, the growing demand for painless Treatment with low cost coupled with increasing aesthetic consciousness among the population has significantly increased the demand for diabetic foot ulcer treatment across different parts of the globe. Additionally, the growing aging population across the globe, which is susceptible to different kinds of ulcer diseases like foot ulcers, is further expected to increase the demand for different dental contouring procedures, thereby fuelling the market growth through 2028. Besides, the growing prevalence of obesity because of leading unhealthy lifestyles across the globe is further expected to support the diabetic foot ulcer treatment market during the forecast period. Furthermore, the growing usage of proper medical equipment and medicines is further expected to increase the demand for diabetic foot ulcer treatment, thereby supporting market growth. According to the Centers for Disease Control and Prevention (CDC), 6 million people aged 18 years or older have prediabetes in the United States, and 26.4 million people aged 65 years or older (48.8%) have prediabetes.
Growing Prevalence of Diabetic Foot Ulcer
The rapidly increasing geriatric population is highly susceptible to chronic diseases such as different types of ulcers. This factor is expected to propel the diabetic foot ulcer treatment market in the next few years. An increase in the prevalence of peripheral vascular as well as sugar-related diseases and other chronic diseases leading to a rising risk of hospital-acquired pressure ulcers is expected to drive the segment during the forecast period. Constantly increasing obesity and peripheral artery diseases among developed and developing countries lead to decreased mobility and increased risk of acquiring chronic ulcers. Similarly, leading unhealthy lifestyles due to consuming junk food and alcohol, people are affected with obesity and diabetes, which will further create ulcers and enhance the growth of the market during the forecast period. In 2019, 37.3 million Americans, or 11.3% of the population, had diabetes. Nearly 1.9 million Americans have type 1 diabetes, including about 244,000 children and adolescents. Diabetic foot ulcers are more common because of the growing incidence in both types of I and maturity-onset diabetes among the aging population in the developing region, which will further propel the growth of the market during the forecast period.
Technological Advancement
Increasing investment and initiative by a government organization for research and development sectors is a major factor driving the market across the globe. An increase in the development of new treatments and advancement in diabetic foot ulcers is expected to create significant growth in the forecast period. For instance, in July 2019, AVITA Medical, g global regenerative medicine company, announced favorable results from an open-label feasibility study of the RECELL Autologous Cell Harvesting Device for the Treatment of Diabetic Foot Ulcers. Increasingly better hospital facility boosts the number of people opting for diabetic foot ulcer treatment. Advanced wound care is rapidly growing, which will further attract new players to invest in this market. Growing development in new biologic products, innovation, and research in skin grafts will further drive the growth of the market over the years.
Market Segmentation
The global diabetic foot ulcer treatment market can be segmented by Treatment, ulcer treatment, End User, and by region. Based on Treatment, the market can be segmented into Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, and Others. Based on ulcer treatment, the market can be differentiated into Neuropathic Ulcers, Ischemic Ulcers, and Neuroischemic Ulcers. Based on End Users, the market can be grouped into Hospitals & Clinics, Ambulatory Care Centers, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global diabetic foot ulcer treatment market.
Recent Developments
- In January 2019, UPM launched a new advanced wound care product in the European market, and FibDex is the product for wound dressing, created from wood-based nano fibrillar cellulose, to receive regulatory approval and to be awarded a CE mark.
Market Players
3M Company, Medtronic Plc, ConvaTec, Inc., Coloplast Corporation, Smith & Nephew Plc, B Braun Melsungen AG, Medline Industries, Inc., Organogenesis, Inc., Molnlycke Health Care AB, Acelity L.P., Inc. are some of the leading players operating in the Global Diabetic Foot Ulcer Treatment Market.
Report Scope
In this report, global diabetic foot ulcer treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Diabetic Foot Ulcer Treatment Market, By Treatment:
- Wound Care Dressings
- Biologics
- Therapy Devices
- Antibiotic Medications
- Others
Diabetic Foot Ulcer Treatment Market, By Ulcer Treatment:
- Neuropathic Ulcers
- Ischemic Ulcers
- Neuroischemic Ulcers
Diabetic Foot Ulcer Treatment Market, By End User:
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
Diabetic Foot Ulcer Treatment Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Diabetic Foot Ulcer Treatment Market.
Available Customizations
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Diabetic Foot Ulcer Treatment Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Others)
- 5.2.2. By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuroischemic Ulcers)
- 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2022)
- 5.3. Market Map
- 5.3.1. By Treatment
- 5.3.2. By Ulcer Type
- 5.3.3. By End User
- 5.3.4. By Region
6. North America Diabetic Foot Ulcer Treatment Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Treatment
- 6.2.2. By Ulcer Type
- 6.2.3. By End User
- 6.2.4. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Diabetic Foot Ulcer Treatment Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Treatment
- 6.3.1.2.2. By Ulcer Type
- 6.3.1.2.3. By End User
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Diabetic Foot Ulcer Treatment Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Treatment
- 6.3.2.2.2. By Ulcer Type
- 6.3.2.2.3. By End User
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Diabetic Foot Ulcer Treatment Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Treatment
- 6.3.3.2.2. By Ulcer Type
- 6.3.3.2.3. By End User
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Diabetic Foot Ulcer Treatment Market Outlook
7. Europe Diabetic Foot Ulcer Treatment Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Treatment
- 7.2.2. By Ulcer Type
- 7.2.3. By End User
- 7.2.4. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Diabetic Foot Ulcer Treatment Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Treatment
- 7.3.1.2.2. By Ulcer Type
- 7.3.1.2.3. By End User
- 7.3.1.1. Market Size & Forecast
- 7.3.2. Germany Diabetic Foot Ulcer Treatment Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Treatment
- 7.3.2.2.2. By Ulcer Type
- 7.3.2.2.3. By End User
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Diabetic Foot Ulcer Treatment Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Treatment
- 7.3.3.2.2. By Ulcer Type
- 7.3.3.2.3. By End User
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Diabetic Foot Ulcer Treatment Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Treatment
- 7.3.4.2.2. By Ulcer Type
- 7.3.4.2.3. By End User
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Diabetic Foot Ulcer Treatment Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Treatment
- 7.3.5.2.2. By Ulcer Type
- 7.3.5.2.3. By End User
- 7.3.5.1. Market Size & Forecast
- 7.3.1. France Diabetic Foot Ulcer Treatment Market Outlook
8. Asia-Pacific Diabetic Foot Ulcer Treatment Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Treatment
- 8.2.2. By Ulcer Type
- 8.2.3. By End User
- 8.2.4. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Diabetic Foot Ulcer Treatment Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Treatment
- 8.3.1.2.2. By Ulcer Type
- 8.3.1.2.3. By End User
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Diabetic Foot Ulcer Treatment Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Treatment
- 8.3.2.2.2. By Ulcer Type
- 8.3.2.2.3. By End User
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Diabetic Foot Ulcer Treatment Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Treatment
- 8.3.3.2.2. By Ulcer Type
- 8.3.3.2.3. By End User
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Diabetic Foot Ulcer Treatment Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Treatment
- 8.3.4.2.2. By Ulcer Type
- 8.3.4.2.3. By End User
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Diabetic Foot Ulcer Treatment Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Treatment
- 8.3.5.2.2. By Ulcer Type
- 8.3.5.2.3. By End User
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Diabetic Foot Ulcer Treatment Market Outlook
9. South America Diabetic Foot Ulcer Treatment Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Treatment
- 9.2.2. By Ulcer Type
- 9.2.3. By End User
- 9.2.4. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Diabetic Foot Ulcer Treatment Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Treatment
- 9.3.1.2.2. By Ulcer Type
- 9.3.1.2.3. By End User
- 9.3.1.1. Market Size & Forecast
- 9.3.2. Argentina Diabetic Foot Ulcer Treatment Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Treatment
- 9.3.2.2.2. By Ulcer Type
- 9.3.2.2.3. By End User
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Colombia Diabetic Foot Ulcer Treatment Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Treatment
- 9.3.3.2.2. By Ulcer Type
- 9.3.3.2.3. By End User
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Brazil Diabetic Foot Ulcer Treatment Market Outlook
10. Middle East and Africa Diabetic Foot Ulcer Treatment Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Treatment
- 10.2.2. By Ulcer Type
- 10.2.3. By End User
- 10.2.4. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Diabetic Foot Ulcer Treatment Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Treatment
- 10.3.1.2.2. By Ulcer Type
- 10.3.1.2.3. By End User
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Saudi Arabia Diabetic Foot Ulcer Treatment Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Treatment
- 10.3.2.2.2. By Ulcer Type
- 10.3.2.2.3. By End User
- 10.3.2.1. Market Size & Forecast
- 10.3.3. UAE Diabetic Foot Ulcer Treatment Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Treatment
- 10.3.3.2.2. By Ulcer Type
- 10.3.3.2.3. By End User
- 10.3.3.1. Market Size & Forecast
- 10.3.4. Turkey Diabetic Foot Ulcer Treatment Market Outlook
- 10.3.4.1. Market Size & Forecast
- 10.3.4.1.1. By Value
- 10.3.4.2. Market Share & Forecast
- 10.3.4.2.1. By Treatment
- 10.3.4.2.2. By Ulcer Type
- 10.3.4.2.3. By End User
- 10.3.4.1. Market Size & Forecast
- 10.3.5. Egypt Diabetic Foot Ulcer Treatment Market Outlook
- 10.3.5.1. Market Size & Forecast
- 10.3.5.1.1. By Value
- 10.3.5.2. Market Share & Forecast
- 10.3.5.2.1. By Treatment
- 10.3.5.2.2. By Ulcer Type
- 10.3.5.2.3. By End User
- 10.3.5.1. Market Size & Forecast
- 10.3.1. South Africa Diabetic Foot Ulcer Treatment Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Recent Developments
- 12.2. Mergers & Acquisitions
- 12.3. Product Launches
13. Competitive Landscape
- 13.1. Business Overview
- 13.2. Product Offerings
- 13.3. Recent Developments
- 13.4. Financials (As Reported)
- 13.5. Key Personnel
- 13.6. SWOT Analysis
- 13.6.1. 3M Company
- 13.6.2. Medtronic Plc
- 13.6.3. ConvaTec, Inc.
- 13.6.4. Coloplast Corporation
- 13.6.5. Smith & Nephew Plc
- 13.6.6. B Braun Melsungen AG
- 13.6.7. Medline Industries, Inc.
- 13.6.8. Organogenesis, Inc.
- 13.6.9. Molnlycke Health Care AB
- 13.6.10. Acelity L.P., Inc.
14. Strategic Recommendations
